DRTS
Alpha Tau Medical Ltd
NASDAQ: DRTS · HEALTHCARE · BIOTECHNOLOGY
$7.37
+0.96% today
Updated 2026-04-29
Market cap
$712.00M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.53
Dividend yield
—
52W range
$3 – $9
Volume
0.3M
Alpha Tau Medical Ltd (DRTS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.91M | $-7.25M | $-11.81M | $-23.88M | $-17.96M | $-19.78M | $-26.68M |
| Capital expenditures | $1.29M | $3.77M | $2.93M | $904000.00 | $6.40M | $2.24M | $6.08M |
| Depreciation | $66000.00 | $86000.00 | $776000.00 | $979000.00 | $1.07M | $1.10M | — |
| Stock-based comp | $546000.00 | $596000.00 | $812000.00 | $6.75M | $7.93M | $9.92M | $10.62M |
| Free cash flow | $-8.20M | $-11.02M | $-14.74M | $-24.78M | $-24.36M | $-22.02M | $-32.76M |
| Investing cash flow | $-10.16M | $-7.82M | $19.27M | $-89.94M | $18.68M | $20.77M | — |
| Financing cash flow | $5.32M | $29.32M | $111000.00 | $96.91M | $5.30M | $25000.00 | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |